The landscape of dementia prognosis has advanced considerably with the advent of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent tests that could detect Alzheimer's pathology several years before signs or symptoms emerge. Although these technological advancements represent extraordinary progress in comprehe